Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Populations news

Show

From To
The Mexico City Policy: An Explainer

On January 23, President Donald Trump reinstated the Mexico City Policy via presidential memorandum. The policy requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning,” using funds from any source (including non-U.S. funds), as a condition for receiving U.S. government global family planning assistance and, as of Jan. 23, 2017, any other U.S. global health assistance.

Published
24 January 2017
From
Kaiser Family Foundation
High prevalence of low testosterone among younger and middle-aged ART-treated men in France

Around one in six young and middle-aged HIV-positive men doing well on antiretroviral therapy (ART) had low testosterone levels, French investigators report in the online edition of

Published
24 January 2017
By
Michael Carter
Trump Strikes at Abortion With a Revived Foreign-Aid Rule

The president has reinstated a contentious policy that blocks funding to international family-planning organizations unless they agree not to promote abortion.

Published
23 January 2017
From
The Atlantic
AT LAST: Gay men and transgender people get vaccine to prevent genital warts and anal cancer – impressive pilot results in England

Gay men and transgender people in England now have limited access to the HPV vaccine. Early results from an ongoing pilot study are extremely encouraging.

Published
18 January 2017
From
HIV i-Base
New HIV prevention treatment can only work if perception improves

A De Montfort University Leicester (DMU) professor and his PhD student have urged the medical profession and media to change the way in which a new HIV prevention treatment is represented if they want it to work. He found that men who would benefit most from taking PrEP were being put off by its association with “high risk” people – as they did not want to place themselves in this category.

Published
18 January 2017
From
De Montfort University (press release)
ChemSex care plan

A new online, interactive resource to assist healthcare practitioners to guide ChemSex patients through a behaviour-change Care Plan, is now live. Designed for people who use chems who might be unable or unwilling to access support services, or for drugs workers/sexual health staff in areas where there are no ChemSex support services

Published
17 January 2017
From
David Stuart
HIV treatment might boost susceptibility to syphilis, say researchers

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Published
17 January 2017
From
Eurekalert Medicine & Health
Criminalization of HIV non-disclosure a bigger burden on women, advocates say

The Supreme Court of Canada has ruled that the consent someone gives to sexual activity can be considered null and void if a partner fails to disclose, or lies about, his or her HIV status.

Published
16 January 2017
From
Toronto Star
HIV diagnoses falling steeply, early figures show: London clinics see hope in increased use of pre-exposure prophylaxis

Early figures from four London sexual health clinics reveal a steep decline in the rate of HIV diagnoses in 2016, raising the possibility that the virus could be managed out of existence in the UK. The fall might be explained by the increased use of medicines called pre-exposure prophylaxis, or PrEP. The medicines are provided by the clinics but are also for sale online, though they are not available on the NHS.

Published
13 January 2017
From
Financial Times
Bacterial communities of female genital tract impact HIV infection risk

More diverse vaginal microbiomes in South African women may underlie increased risk

Published
12 January 2017
From
Ragon Institute

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.